Indian shares drop 1.1 pct; Maruti falls, Fortis up

MUMBAI, July 1 (Reuters) – Indian shares got off to a shaky start to the new quarter, falling 1.1 percent on Thursday as doubts resurfaced about the global economic recovery and a slower manufacturing growth at home.

A survey showed Indian manufacturing growth cooled in June from a surge in activity the prior month, mainly due to slowing production and rapidly easing input price pressures. [ID:nBMA007940]

Leading car maker Maruti Suzuki (MRTI.BO) fell as much as 3.1 percent after sales growth in June slowed from the previous month, partly due to a 6-day shutdown of its plants for maintenance work. [ID:nSGE660080]

Asian stocks dropped as manufacturing data showed China’s rapid economic growth was slowing and as fresh worries about Europe’s fiscal health hit risk appetite.

“The scene is not looking good in the near term. We have some or the other bad news coming in from Europe every other day,” said Kunal Sukhani, manager of institutional equities at brokerage Asian Markets Securities.

Shares in Fortis Healthcare (FOHE.BO) swung widely after the company launched a bid valuing Singapore hospital operator Parkway Holdings (PARM.SI) at $3.1 billion, topping a bid by rival suitor Malaysian state fund Khazanah. [ID:nSGE66002F]

By 11:17 a.m. (0547 GMT), the 30-share BSE index .BSESN was trading down 1.07 percent at 17,512.18, with 27 of its components declining.

Fortis was trading 1.5 percent higher after falling as much as 3.4 percent.

Financials dropped ahead of food and fuel price data due around 0630 GMT.

Top lender State Bank of India (SBI.BO) was down 1.1 percent while rivals ICICI Bank (ICBK.BO) and HDFC Bank (HDBK.BO) dropped 2.4 percent and 0.7 percent respectively.

In the broader market, gainers and losers were almost equal in number on volume of 169 million shares.

The 50-share NSE index was down 1.2 percent at 5,250.25.

The BSE index rose 4.5 percent in June, posting its best monthly gain since March. The rise was powered by foreign funds who pumped in $2.1 billion June 1-29, reversing withdrawal of $2 billion in May when the benchmark fell 3.5 percent.

For April-June, the index rose 1 percent, climbing for the sixth straight quarter in its longest run in at least 20 years.

STOCKS ON THE MOVE

* TVS Motor Co (TVSM.BO) was up 1.6 percent at 121.15 rupees as June two-wheeler sales of the No. 3 motorcycle maker rose 36 percent from the same period a year earlier. [ID:nBMB010904]

* Drug maker Parabolic Drugs (PARB.BO) (PARB.NS) debuted on the BSE at 76.8 rupees, up 2.4 percent from its issue price of 75 rupees. [ID:nSGE660056]

The stock erased all gains and was trading lower at 66.95 rupees.

MAIN TOP 3 BY VOLUME

* Redington (REDI.BO) on 11.5 million shares

* IFCI (IFCI.BO) on 6.4 million shares

* Parabolic Drugs on 3.9 million shares

FACTORS TO WATCH * For technical analysis double click on www.reutersindia.net * Indian rupee report [INR/] * Indian bond report [IN/] * Euro hits record low vs Swiss franc, Aussie down [FRX/] * Oil tumbles 4th day on China economic growth worries [O/R] * Stocks, commodities fall on China slowdown [MKTS/GLOB] * Wall St tumbles to worst quarter since Lehman fall [.N] * For closing rates of Indian ADRs INADR (Reporting by Ami Shah; Editing by Ranjit Gangadharan)

India’s Fortis makes $3.1 bln offer for Parkway

July 1 (Reuters) – India’s Fortis Healthcare (FOHE.BO) unveiled a general offer to buy shares in Singapore hospital operator Parkway Holdings (PARM.SI) for S$3.80 a share.

The bid, which values Parkway at S$4.32 billion ($3.1 billion), is 2 Singapore cents higher than the S$3.78 per share offered by Malaysian state investor Khazanah under its partial offer, and versus Parkway’s last closing price of S$3.57.

Fortis will have to pay S$3.23 billion for shares of Parkway that it does not already own.

The offer is conditional on Fortis getting at least 50 percent of the Singapore firm.

Shares in Parkway were halted for trading on Thursday. ($1=1.398 Singapore Dollar) (Reporting by Kevin Lim; Editing by Anshuman Daga)

UPDATE 2-GIC defers preferential funding in India’s Fortis

NEW DELHI/SINGAPORE, June 25 (Reuters) – Indian hospital
operator Fortis Healthcare (FOHE.BO) said the Government of
Singapore Investment Corp (GIC) had decided to defer a
preferential investment but the sovereign wealth fund will
evaluate participating in broader fund raising by Fortis.

Controlled by Indian billionaire brothers Malvinder Singh
and Shivinder Singh, Fortis is pitted against Malaysian state
fund Khazanah for control of Parkway Holdings (PARM.SI).

Fortis will have to offer more than $2.3 billion to buy all
of the Singapore-based hospital chain.

Both Fortis and Khazanah want to use Parkway, which runs 16
hospitals across Asia including Singapore, Malaysia, India and
China to spearhead their regional expansion into healthcare.

In a statement on Friday, the Indian firm, which already
holds roughly 25 percent of Parkway quoted GIC [GIC.UL] as
saying it remains committed to Fortis through its substantial
investment in Fortis’ convertible bonds. GIC declined comment
beyond the statement by Fortis.

Fortis had wanted to build a controlling stake in Parkway
but Khazanah made a surprise $835 million offer last month to
lift its stake from 23.5 percent to 51.5 percent.

“The statement doesn’t necessarily mean GIC is committed to
the cause of Fortis,” said Ranjit Kapadia, an analyst at
Mumbai-based HDFC Securities.

“GIC may not be willing to pay a premium of 11 percent on
the current market price of Fortis and that may have led to the
deferment of allotment.”

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

For a FACTBOX on Parkway: [ID:nSGE653028]

For a Scenarios story on the tussle: [ID:nSGE65F070]

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

KEY ASSETS

Parkway’s prized assets are Singapore hospitals, Gleneagles
and Mount Elizabeth, whose patients include many wealthy
businessmen and politicians. [ID:nSGE653028]

With a combined fortune estimated at $3 billion by Forbes
magazine — good for 17th place on its India rich list — the
Singh brothers have the means and access to capital to take on
the Malaysian fund if, as some expect, they choose to do so.

Fortis had earlier agreed to allot shares worth 3.8 billion
rupees ($82 million) to GIC.

“It’s political. It would not look right if GIC is seen
supporting Fortis when Khazanah is on the other side,” said a
Singapore-based trader, who did not want to be named.

He said the market does not think Fortis will make a
counterbid, given the risk of Parkway losing its control over
Malaysia’s Pantai, he added.

By 0645 GMT, Fortis shares were down 0.9 percent, while
Parkway shares were little changed.

Most of Parkway’s operations in Malaysia are carried out
via Pantai, in which it holds a 40 percent with the balance
held by Khazanah.

Pantai accounts for a quarter of Parkway’s revenue and
almost one-third of earnings before interest, tax,
depreciation, amortisation and rent, according to Credit
Suisse.

Khazanah launched a bid for Parkway a week after the
leaders of Singapore and Malaysia agreed to resolve
long-standing disputes over land and water that have plagued
ties between the two countries for the past 20 years.

Fortis also said it had approved the conversion of warrants
into shares totaling 13.42 billion rupees. These warrants were
issued last year with a rights issue.

Singapore’s securities regulator has given Fortis until
July 30 to say whether it intends to make a full offer for
Parkway. [ID:nSGE65F0ES]
($1=46.5 rupees)
(Reporting by Sanjeev Choudhary and Sumeet Chatterjee in NEW
DELHI and Kevin Lim in SINGAPORE; Editing by Ranjit Gangadharan
and Anshuman Daga)

Australia’s Healthscope gets 2 more takeover offers

(Reuters) – Australian hospital operator Healthscope (HSP.AX) said on Monday it has got two more takeover offers valuing the company at more than A$1.84 billion ($1.56 billion) as a bidding war intensifies.

Deals

The offer price of A$5.80 a share was 0.9 percent higher than an existing offer for the group and a 10.9 per cent premium to Friday’s closing share price.

The shares rose 5.7 percent to A$5.53 in early trade, a 4.6 percent discount to the latest offer.

Healthscope in a statement advised shareholders to take no action and added it would take several weeks to evaluate the offer.

Last week, a source said private equity firm Blackstone Group LP (BX.N) had joined TPG and Carlyle in their bid at A$5.75 a share.

Private equity firm Kohlberg Kravis Roberts was also planning to lodge a bid for the company, media reports said Monday.

At least three analysts have put valuations of between A$5.80 and A$6.70 on Healthscope if the company’s hospitals and pathology arms were broken up.

The bid would be the largest private equity bid in Australia since 2008.

(Reporting by Michael Smith; Editing by Ed Davies)

Australia’s Healthscope gets 2 more takeover offers

May 31 (Reuters) – Australian hospital operator Healthscope (HSP.AX) said on Monday it has got two more takeover offers at a price of A$5.80 a share or 0.9 percent higher than the existing offer.

Private Capital | Financials | Healthcare

The offer at a 10.9 percent premium to Friday’s closing share price values the firm at A$1.84 billion ($1.56 billion).

Healthscope in a statement advised shareholders to take no action and added it would take several weeks to evaluate the offer.

Last week, a source said private equity firm Blackstone Group LP (BX.N) had joined TPG and Carlyle in their bid at A$5.75 a share. [ID:nSGE64N1WX] ($1=1.180 Australian Dollar) (Reporting by Narayanan Somasundaram; Editing by Ed Davies)